FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/04/108406 [Registered on: 15/04/2026] Trial Registered Prospectively
Last Modified On: 10/09/2026
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Medical Device 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Using Virtual Reality and Simple Computer Tasks To Understand Recovery in People Struggling with Alcohol Use.  
Scientific Title of Study   Evaluating the Association of Addictions Neuroclinical Assessments based Measures with Treatment Outcomes and their Change following Virtual Reality Cue Exposure In Individuals with Alcohol Use Disorder 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
Modification(s)  
Name  Ananya Mishra 
Designation  PhD Scholar, Dept of Psychiatry, AIIMS Bhopal 
Affiliation  AIIMS Bhopal 
Address  AIIMS Campus Rd, Saket Nagar, Habib Ganj Bhopal, Madhya Pradesh

Bhopal
MADHYA PRADESH
462020
India 
Phone  9575057740  
Fax    
Email  ananya0503@icloud.com  
 
Details of Contact Person
Scientific Query

Modification(s)  
Name  Dr. Vijender Singh 
Designation  Professor, Head of Dept of Psychiatry, AIIMS Bhopal 
Affiliation  AIIMS Bhopal 
Address  AIIMS Campus Rd, Saket Nagar, Habib Ganj Bhopal, Madhya Pradesh

Bhopal
MADHYA PRADESH
462020
India 
Phone  9810930723  
Fax    
Email  vijender.psy@aiimsbhopal.edu.in  
 
Details of Contact Person
Public Query

Modification(s)  
Name  Ananya Mishra  
Designation  PhD Scholar, Dept of Psychiatry, AIIMS Bhopal 
Affiliation  AIIMS Bhopal 
Address  AIIMS Campus Rd, Saket Nagar, Habib Ganj Bhopal, Madhya Pradesh

Bhopal
MADHYA PRADESH
462020
India 
Phone  9575057740  
Fax    
Email  ananya0503@icloud.com  
 
Source of Monetary or Material Support  
All India Institute of Medical Sciences, AIIMS Campus Road, Saket Nagar, Habib Ganj, Bhopal, Madhya Pradesh, Pin Code: 462020 
 
Primary Sponsor  
Name  All India Institute of Medical Sciences Bhopal 
Address  AIIMS Campus Rd, Saket Nagar, Habib Gang, Bhopal, Madhya Pradesh, PIN code: 462020 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study
Modification(s)  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Vijender Singh  All India Institute of Medical Sciences  Psychiatry Department, AIIMS Campus, Saket Nagar, Habib Ganj, Pin Code: 462020
Bhopal
MADHYA PRADESH 
9810930723

vijender.psy@aiimsbhopal.edu.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Human Ethics Committee-Student Research (IHEC-SR)  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: F102||Alcohol dependence,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  TAU arm   This arm will be given Treatment as usual care of AUD patients in psychiatry ward (standard medicines and psychotherapy)  
Intervention  Virtual Reality Cue Exposure (VRCE)  Multiple sessions of VRCE will be administered to experiment group where they will be exposed to alcohol related cues such as rooms with alcohol bottles present.  
 
Inclusion Criteria  
Age From  25.00 Year(s)
Age To  50.00 Year(s)
Gender  Male 
Details  Diagnosis of Alcohol Use Disorder (AUD) as per DSM-5 criteria, Currently admitted to the inpatient psychiatry unit at AIIMS Bhopal, Able to understand instructions and perform computerized tasks in Hindi or English, None or mild alcohol withdrawal at the time of assessment Willing and able to provide written informed consent, Willing and eligible for disulfiram as a pharmacological treatment at the time of discharge. 
 
ExclusionCriteria 
Details  1. Comorbid psychiatric disorders (e.g., schizophrenia, bipolar disorder) or other
substance use disorders, excluding nicotine
2. Comorbid neurological conditions that interfere with computerized assessment or
VR use (e.g., epilepsy, traumatic brain injury, seizure disorders)
3. Severe cognitive impairment (as determined by clinical judgment or documented
history) that prevents meaningful task engagement
4. Visual or motor impairments that limit the ability to interact with computerized
or VR-based tasks
5. Current use of medications or medical conditions that may significantly affect
cognitive functioning (e.g., delirium, heavy sedation)
6. Current use of medications or medical conditions that can affect craving (e.g.,
Naltrexone, Baclofen etc. )
7. History of severe motion sickness/vertigo, severe migraine triggered by visual
stimuli 
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
The primary treatment outcome that will be measured is Craving via the Penn Alcohol Craving Scale (PACS).   4-week follow-up post discharge (+/- 1 week) 
 
Secondary Outcome  
Outcome  TimePoints 
Pattern of Alcohol Consumption, coping, readiness etc via TLFB, RCQ, semi structured proforma, Brief Cope Scale etc   same as primary outcome, i.e. 4 week post discharge 
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1 
Date of First Enrollment (India)   01/09/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details
Modification(s)  
N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  
This study is a prospective pretest-post test control group design to examine the association of Addictions Neuroclinical Assessment (ANA) based measures with treatment outcomes in Alcohol Use Disorder (AUD) after a Virtual Reality Cue Exposure (VRCE) intervention. Fifty inpatients with AUD admitted to the Psychiatry Ward at AIIMS Bhopal will be recruited using purposive sampling and randomly allocated to either a Virtual Reality Cue Exposure (VRCE) + Treatment as usual (TAU) control group. After stabilization patients will complete baseline behavioural tasks and self report measures. VRCE intervention will be given to experiment group and TAU to control group. Follow up measures will be conducted 4 weeks post discharge. Change in results of ANA measures will be compared pre and post intervention as well as its effect on treatment outcomes.  
Close